Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 802

1.

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ.

Br J Cancer. 2020 Mar 12. doi: 10.1038/s41416-020-0767-0. [Epub ahead of print]

PMID:
32203217
2.

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.

Archer S, Babb de Villiers C, Scheibl F, Carver T, Hartley S, Lee A, Cunningham AP, Easton DF, McIntosh JG, Emery J, Tischkowitz M, Antoniou AC, Walter FM.

PLoS One. 2020 Mar 6;15(3):e0229999. doi: 10.1371/journal.pone.0229999. eCollection 2020.

3.

Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial.

Walter FM, Pannebakker MM, Barclay ME, Mills K, Saunders CL, Murchie P, Corrie P, Hall P, Burrows N, Emery JD.

JAMA Netw Open. 2020 Feb 5;3(2):e200001. doi: 10.1001/jamanetworkopen.2020.0001.

4.

External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank.

Saunders CL, Kilian B, Thompson DJ, McGeoch LJ, Griffin SJ, Antoniou AC, Emery JD, Walter FM, Dennis J, Yang X, Usher-Smith JA.

Cancer Prev Res (Phila). 2020 Feb 18. pii: canprevres.0521.2019. doi: 10.1158/1940-6207.CAPR-19-0521. [Epub ahead of print]

PMID:
32071122
5.

Using an electronic self-completion tool to identify patients at increased risk of melanoma in Australian primary care.

Habgood E, Walter FM, O'Hare E, McIntosh J, McCormack C, Emery JD.

Australas J Dermatol. 2020 Feb 12. doi: 10.1111/ajd.13244. [Epub ahead of print]

PMID:
32050041
6.

Patient symptom experience prior to a diagnosis of oesophageal or gastric cancer: a multi-methods study.

Humphrys E, Walter FM, Rubin G, Emery JD, Johnson M, Richards A, Fitzgerald RC, Viswanath YK, Burt J.

BJGP Open. 2020 Jan 7. pii: bjgpopen20X101001. doi: 10.3399/bjgpopen20X101001. [Epub ahead of print]

7.

Episodes of particle ejection from the surface of the active asteroid (101955) Bennu.

Lauretta DS, Hergenrother CW, Chesley SR, Leonard JM, Pelgrift JY, Adam CD, Al Asad M, Antreasian PG, Ballouz RL, Becker KJ, Bennett CA, Bos BJ, Bottke WF, Brozović M, Campins H, Connolly HC Jr, Daly MG, Davis AB, de León J, DellaGiustina DN, Drouet d'Aubigny CY, Dworkin JP, Emery JP, Farnocchia D, Glavin DP, Golish DR, Hartzell CM, Jacobson RA, Jawin ER, Jenniskens P, Kidd JN Jr, Lessac-Chenen EJ, Li JY, Libourel G, Licandro J, Liounis AJ, Maleszewski CK, Manzoni C, May B, McCarthy LK, McMahon JW, Michel P, Molaro JL, Moreau MC, Nelson DS, Owen WM Jr, Rizk B, Roper HL, Rozitis B, Sahr EM, Scheeres DJ, Seabrook JA, Selznick SH, Takahashi Y, Thuillet F, Tricarico P, Vokrouhlický D, Wolner CWV.

Science. 2019 Dec 6;366(6470). pii: eaay3544. doi: 10.1126/science.aay3544.

PMID:
31806784
8.

Practitioners' Views on Nicotine Replacement Therapy in Pregnancy during Lapse and for Harm Reduction: A Qualitative Study.

Thomson R, McDaid L, Emery J, Phillips L, Naughton F, Cooper S, Dyas J, Coleman T.

Int J Environ Res Public Health. 2019 Nov 29;16(23). pii: E4791. doi: 10.3390/ijerph16234791.

9.

Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care.

Nguyen P, McIntosh J, Bickerstaffe A, Maddumarachchi S, Cummings KL, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e843-e849. doi: 10.3399/bjgp19X706613. Print 2019 Dec.

PMID:
31740461
10.

Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review.

Chima S, Reece JC, Milley K, Milton S, McIntosh JG, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e809-e818. doi: 10.3399/bjgp19X706745. Print 2019 Dec.

PMID:
31740460
11.

Childhood cancer survivorship: barriers and preferences.

Signorelli C, Wakefield C, McLoone JK, Fardell J, Jones JM, Turpin KH, Emery J, Michel G, Downie P, Skeen JE, Cohn R; ANZCHOG Survivorship Study Group; members of the ANZCHOG Survivorship Study Group.

BMJ Support Palliat Care. 2019 Nov 11. pii: bmjspcare-2019-002001. doi: 10.1136/bmjspcare-2019-002001. [Epub ahead of print]

PMID:
31712388
12.

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines.

Funston G, Van Melle M, Baun ML, Jensen H, Helsper C, Emery J, Crosbie EJ, Thompson M, Hamilton W, Walter FM.

BMC Cancer. 2019 Nov 1;19(1):1028. doi: 10.1186/s12885-019-6211-2.

13.

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

McIntosh JG, Minshall J, Saya S, Bickerstaffe A, Hewabandu N, Qama A, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e836-e842. doi: 10.3399/bjgp19X706841. Print 2019 Dec.

PMID:
31636127
14.

Tracking-A Flexible Obstetrics and Gynecology Residency Curriculum.

Reed VR, Emery J, Farrell RM, Jelovsek JE.

Obstet Gynecol. 2019 Oct;134 Suppl 1:29S-33S. doi: 10.1097/AOG.0000000000003464.

PMID:
31568038
15.

Exploring the Business Case for Improving Quality of Care for Patients With Chronic Rotator Cuff Tears.

Eubank BH, Emery JCH, Lafave MR, Wiley JP, Sheps DM, Mohtadi NG.

Qual Manag Health Care. 2019 Oct/Dec;28(4):209-221. doi: 10.1097/QMH.0000000000000231.

PMID:
31567844
16.

Microfluidic electrochemical cell for in situ structural characterization of amorphous thin-film catalysts using high-energy X-ray scattering.

Kwon G, Cho YH, Kim KB, Emery JD, Kim IS, Zhang X, Martinson ABF, Tiede DM.

J Synchrotron Radiat. 2019 Sep 1;26(Pt 5):1600-1611. doi: 10.1107/S1600577519007240. Epub 2019 Aug 9.

17.

Dermoscopy for melanoma detection and triage in primary care: a systematic review.

Jones OT, Jurascheck LC, van Melle MA, Hickman S, Burrows NP, Hall PN, Emery J, Walter FM.

BMJ Open. 2019 Aug 20;9(8):e027529. doi: 10.1136/bmjopen-2018-027529.

18.

Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases.

Yee J, Davis GM, Hackett D, Beith JM, Wilcken N, Currow D, Emery J, Phillips J, Martin A, Hui R, Harrison M, Segelov E, Kilbreath SL.

J Pain Symptom Manage. 2019 Dec;58(6):929-939. doi: 10.1016/j.jpainsymman.2019.07.022. Epub 2019 Jul 30.

PMID:
31374368
19.

Evidence for widespread hydrated minerals on asteroid (101955) Bennu.

Hamilton VE, Simon AA, Christensen PR, Reuter DC, Clark BE, Barucci MA, Bowles NE, Boynton WV, Brucato JR, Cloutis EA, Connolly HC Jr, Hanna KLD, Emery JP, Enos HL, Fornasier S, Haberle CW, Hanna RD, Howell ES, Kaplan HH, Keller LP, Lantz C, Li JY, Lim LF, McCoy TJ, Merlin F, Nolan MC, Praet A, Rozitis B, Sandford SA, Schrader DL, Thomas CA, Zou XD, Lauretta DS; OSIRIS-REx Team.

Nat Astron. 2019;3(4):332-340. doi: 10.1038/s41550-019-0722-2. Epub 2019 Mar 19.

20.

Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, Rubin G, Singh H, Walter FM, de Wit NJ, Lyratzopoulos G.

Nat Rev Clin Oncol. 2019 Dec;16(12):746-761. doi: 10.1038/s41571-019-0249-6. Epub 2019 Jul 26. Review.

21.

Tools to facilitate communication during physician-patient consultations in cancer care: An overview of systematic reviews.

Licqurish SM, Cook OY, Pattuwage LP, Saunders C, Jefford M, Koczwara B, Johnson CE, Emery JD.

CA Cancer J Clin. 2019 Nov;69(6):497-520. doi: 10.3322/caac.21573. Epub 2019 Jul 24. Review.

22.

Targeting IRAK4 for Degradation with PROTACs.

Nunes J, McGonagle GA, Eden J, Kiritharan G, Touzet M, Lewell X, Emery J, Eidam H, Harling JD, Anderson NA.

ACS Med Chem Lett. 2019 Jun 14;10(7):1081-1085. doi: 10.1021/acsmedchemlett.9b00219. eCollection 2019 Jul 11.

PMID:
31312412
23.

Risk Prediction Models for Colorectal Cancer Incorporating Common Genetic Variants: A Systematic Review.

McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, Antoniou AC, Usher-Smith JA.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1580-1593. doi: 10.1158/1055-9965.EPI-19-0059. Epub 2019 Jul 10. Review.

PMID:
31292139
24.

Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners.

Delatycki MB, Laing NG, Moore SJ, Emery J, Archibald AD, Massie J, Kirk EP.

Aust J Gen Pract. 2019 Mar;48(3):106-110. doi: 10.31128/AJGP-10-18-4725.

25.

Preparing for the genomics era.

Emery J.

Aust J Gen Pract. 2019 Mar;48(3):81. doi: 10.31128/AJGP-01-19-4832. No abstract available.

26.

Genomics.

Emery J.

Aust J Gen Pract. 2019 Mar;48(3):81. doi: 10.31128/AJGP-01-19-4832. No abstract available.

PMID:
31256464
27.

The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.

Harty EC, McIntosh JG, Bickerstaffe A, Hewabandu N, Emery JD.

Fam Pract. 2019 Nov 18;36(6):730-735. doi: 10.1093/fampra/cmz029.

PMID:
31237329
28.

Chemoprevention: A new concept for cancer prevention in primary care

Emery JD, Nguyen P, Minshall J, Cummings KL, Walker J.

Aust J Gen Pract. 2018 Dec;47(12):825-828. doi: 10.31128/AJGP-07-18-4644.

29.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL.

Fam Cancer. 2019 Oct;18(4):389-397. doi: 10.1007/s10689-019-00136-6.

PMID:
31209717
30.

Evaluating diagnostic strategies for early detection of cancer: the CanTest framework.

Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD.

BMC Cancer. 2019 Jun 14;19(1):586. doi: 10.1186/s12885-019-5746-6.

31.

Lung cancer.

Neal RD, Sun F, Emery JD, Callister ME.

BMJ. 2019 Jun 3;365:l1725. doi: 10.1136/bmj.l1725. No abstract available.

32.

Knowledge and Education as Barriers and Facilitators to Nicotine Replacement Therapy Use for Smoking Cessation in Pregnancy: A Qualitative Study with Health Care Professionals.

Thomson R, McDaid L, Emery J, Naughton F, Cooper S, Dyas J, Coleman T.

Int J Environ Res Public Health. 2019 May 22;16(10). pii: E1814. doi: 10.3390/ijerph16101814.

33.

Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation.

Pannebakker MM, Mills K, Johnson M, Emery JD, Walter FM.

BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101635. doi: 10.3399/bjgpopen18X101635. eCollection 2019 Apr.

34.

Research evidence supports cancer policymaking but is insufficient for change: Findings of key informant interviews from five countries.

Bergin RJ, Emery J, Bollard R, White V.

Health Policy. 2019 Jun;123(6):572-581. doi: 10.1016/j.healthpol.2019.04.003. Epub 2019 Apr 13.

PMID:
31005343
35.

Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology.

Jones OT, Jurascheck LC, Utukuri M, Pannebakker MM, Emery J, Walter FM.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1706-1712. doi: 10.1111/jdv.15614. Epub 2019 May 17.

36.

Gathering data for decisions: best practice use of primary care electronic records for research.

Canaway R, Boyle DI, Manski-Nankervis JE, Bell J, Hocking JS, Clarke K, Clark M, Gunn JM, Emery JD.

Med J Aust. 2019 Apr;210 Suppl 6:S12-S16. doi: 10.5694/mja2.50026.

37.

A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol.

Philip J, Collins A, Le B, Sundararajan V, Brand C, Hanson S, Emery J, Hudson P, Mileshkin L, Ganiatsas S.

Pilot Feasibility Stud. 2019 Mar 14;5:44. doi: 10.1186/s40814-019-0424-7. eCollection 2019.

38.

The unexpected surface of asteroid (101955) Bennu.

Lauretta DS, DellaGiustina DN, Bennett CA, Golish DR, Becker KJ, Balram-Knutson SS, Barnouin OS, Becker TL, Bottke WF, Boynton WV, Campins H, Clark BE, Connolly HC Jr, Drouet d'Aubigny CY, Dworkin JP, Emery JP, Enos HL, Hamilton VE, Hergenrother CW, Howell ES, Izawa MRM, Kaplan HH, Nolan MC, Rizk B, Roper HL, Scheeres DJ, Smith PH, Walsh KJ, Wolner CWV; OSIRIS-REx Team.

Nature. 2019 Apr;568(7750):55-60. doi: 10.1038/s41586-019-1033-6. Epub 2019 Mar 19.

39.

Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: A secondary qualitative analysis across seven cancers.

Kummer S, Walter FM, Chilcot J, Emery J, Sutton S, Scott SE.

Psychooncology. 2019 May;28(5):1041-1047. doi: 10.1002/pon.5049. Epub 2019 Mar 18.

PMID:
30828881
40.

Spotting the old foe-revisiting the case definition for TB.

Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F.

Lancet Respir Med. 2019 Mar;7(3):199-201. doi: 10.1016/S2213-2600(19)30038-4. No abstract available.

PMID:
30823971
41.

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA.

JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.

42.

The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.

Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza D, Habgood E, Kutzer Y, Barnes DJ, Murchie P.

Thorax. 2019 Apr;74(4):362-370. doi: 10.1136/thoraxjnl-2018-212506. Epub 2019 Jan 10.

43.

Development of an intervention to expedite cancer diagnosis through primary care: a protocol.

Stanciu MA, Law RJ, Nafees S, Hendry M, Yeo ST, Hiscock J, Lewis R, Edwards RT, Williams NH, Brain K, Brocklehurst P, Carson-Stevens A, Dolwani S, Emery J, Hamilton W, Hoare Z, Lyratzopoulos G, Rubin G, Smits S, Vedsted P, Walter F, Wilkinson C, Neal RD; WICKED Team on behalf of.

BJGP Open. 2018 Sep 5;2(3):bjgpopen18X101595. doi: 10.3399/bjgpopen18X101595. eCollection 2018 Oct.

44.

The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia.

Mileshkin L, Dunn C, Cross H, Duffy M, Shaw M, Antippa P, Mitchell P, Akhurst T, Conron M, Moore M, Philip J, Bartlett J, Emery J, Zambello B.

Intern Med J. 2019 Aug;49(8):1001-1006. doi: 10.1111/imj.14183.

PMID:
30515932
45.

A pilot study comparing peer supported web-based CBT to self-managed web CBT for primary care veterans with PTSD and hazardous alcohol use.

Possemato K, Johnson EM, Emery JB, Wade M, Acosta MC, Marsch LA, Rosenblum A, Maisto SA.

Psychiatr Rehabil J. 2019 Sep;42(3):305-313. doi: 10.1037/prj0000334. Epub 2018 Nov 29.

PMID:
30489140
46.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.

PMID:
30445378
47.

Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.

Vázquez-Rosa E, Watson MR, Sahn JJ, Hodges TR, Schroeder RE, Cintrón-Pérez CJ, Shin MK, Yin TC, Emery JL, Martin SF, Liebl DJ, Pieper AA.

ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.

48.

Revised Australian national guidelines for colorectal cancer screening: family history.

Jenkins MA, Ait Ouakrim D, Boussioutas A, Hopper JL, Ee HC, Emery JD, Macrae FA, Chetcuti A, Wuellner L, St John DJB.

Med J Aust. 2018 Nov 19;209(10):455-460. Epub 2018 Oct 29.

PMID:
30359558
49.

The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review.

Humphrys E, Burt J, Rubin G, Emery JD, Walter FM.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12920. doi: 10.1111/ecc.12920. Epub 2018 Oct 16.

50.

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1450-1461. doi: 10.1158/1055-9965.EPI-18-0128. Epub 2018 Sep 6.

Supplemental Content

Support Center